Elevated Oral and Systemic Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Periodontitis
dc.contributor.author | Bostanci, N. | |
dc.contributor.author | Ozturk, V. O. | |
dc.contributor.author | Emingil, G. | |
dc.contributor.author | Belibasakis, G. N. | |
dc.date.accessioned | 2019-10-27T21:42:01Z | |
dc.date.available | 2019-10-27T21:42:01Z | |
dc.date.issued | 2013 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | The Triggering Receptor Expressed on Myeloid cells 1 (TREM-1) is a cell-surface receptor of the immunoglobulin superfamily, involved in the propagation of the inflammatory response to bacterial challenge. Soluble (s) TREM-1 is released from the cell surface during the course of infection and is a useful inflammatory biomarker in the early diagnosis of systemic sepsis. The hypothesis of this study was that oral and systemic levels of sTREM-1 are elevated in periodontitis. Therefore, the aim was to investigate, by ELISA, the sTREM-1 concentrations in saliva and serum of individuals without periodontitis (control) and persons with chronic or generalized aggressive periodontitis. In saliva, sTREM-1 concentrations were higher in chronic and aggressive periodontitis than in the control group, by 3.3-fold and 5.6-fold, respectively. In serum, these differences were 1.7-fold and 2-fold, respectively. However, there were no significant differences between the two forms of periodontitis, neither in saliva nor in serum. Salivary and serum sTREM-1 levels positively correlated with full-mouth clinical periodontal parameters. In conclusion, the increased oral and systemic levels of sTREM-1 in periodontitis denote a value for this molecule as a biomarker for the disease and may also have implications in the association between periodontal infections and systemic inflammatory response. | en_US |
dc.identifier.doi | 10.1177/0022034512470691 | en_US |
dc.identifier.endpage | 165 | en_US |
dc.identifier.issn | 0022-0345 | |
dc.identifier.issn | 1544-0591 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 23242230 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 161 | en_US |
dc.identifier.uri | https://doi.org/10.1177/0022034512470691 | |
dc.identifier.uri | https://hdl.handle.net/11454/46804 | |
dc.identifier.volume | 92 | en_US |
dc.identifier.wos | WOS:000313629700011 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Inc | en_US |
dc.relation.ispartof | Journal of Dental Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | TREM-1 protein | en_US |
dc.subject | saliva | en_US |
dc.subject | serum | en_US |
dc.subject | inflammation | en_US |
dc.subject | periodontal diseases | en_US |
dc.subject | ELISA | en_US |
dc.title | Elevated Oral and Systemic Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Periodontitis | en_US |
dc.type | Article | en_US |